SCHEMBL4852088

SCHEMBL4852088

CC(C)(C)OC(=O)NCCC[C@H](CNC(=O)CN(Cc1ccccc1)C(=O)O)NC(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.48
ATM Q13315 1/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MMP1 P03956 1/20 0.44
MMP3 P08254 1/20 0.44
MMP9 P14780 1/20 0.44
CTSS P25774 3/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
MAPT P10636 2/20 0.44
GAA P10253 1/20 0.44
CTSK P43235 3/20 0.43
SIGMAR1 Q99720 2/20 0.41
PAX8 Q06710 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
IDO1 P14902 1/20 0.41
AKT1 P31749 2/20 0.40
APP P05067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1024156 1.00 SYK (0.48) SYKATMMEN1KMT2AMMP1
SCHEMBL4847719 0.90 SYK (0.47) SYKATMMEN1KMT2AMMP1
SCHEMBL4847703 0.90 SYK (0.47) SYKATMMEN1KMT2AMMP1
SCHEMBL1023321 0.89 SYK (0.46) SYKATMMEN1KMT2AMMP1
SCHEMBL4848854 0.89 SYK (0.46) SYKATMMEN1KMT2AMMP1
SCHEMBL4853602 0.85 SYK (0.47) SYKATMMEN1KMT2AMMP1
SCHEMBL1072867 0.85 SYK (0.47) SYKATMMEN1KMT2AMMP1
SCHEMBL1023983 0.84 SYK (0.42) SYKATMMEN1KMT2AMMP1
SCHEMBL4850221 0.83 SYK (0.49) SYKATMMEN1KMT2AMMP1
SCHEMBL4850228 0.83 SYK (0.49) SYKATMMEN1KMT2AMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446102-B2 Antibacterial amide macrocycles IV AICURIS GMBH & CO. KG (DE) 2008-11-04 US disclosed
US-20080076745-A1 ANTIBACTERIAL AMIDE MACROCYCLES IV AICURIS GMBH & CO. KG (DE) 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076745-A1 ANTIBACTERIAL AMIDE MACROCYCLES IV NOD2, AAAS, AADAC SYK 3060/4885ATM 2832/4885MEN1 2081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.